American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) — Bethesda, Maryland

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) is a clinical research site located in Bethesda, Maryland, United States 20817.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Polycythemia Vera, Tumor, Tumor, Solid.

Sponsors: PharmaEssentia, Aadi Bioscience, Inc., Protagonist Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders)?

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) conducted?

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) has 3 clinical trials on record, with 3 currently active. Their work covers Polycythemia Vera, Tumor, Tumor, Solid.

Is American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) accredited by Crixeo Health?

American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about American Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.